Organisation paid for research Program year 2025 Source: CMS Open Payments

Usdh Clinical Research LLC

Neither a doctor nor a teaching hospital

Research payments

$710,324

171 payments

Through program year 2025, Usdh Clinical Research LLC is reported as receiving $710,324 in research payments, across 171 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$210,756	47
2024	Research	$428,045	107
2023	Research	$71,523	17

Breakdown

Who paid Research payments · program years 2023–2025

GlaxoSmithKline, LLC. $586,704 146 payments
Madrigal Pharmaceuticals $106,577 24 payments
AbbVie, Inc. $17,042 1 payment

Studies the money was for Research payments · program years 2023–2025

17 B-Hydroxysteroid Dehydrogenase Type 13 Minimization for the Treatme $586,704 146 payments
A 52-Week, Phase 3, Open-Label Extension Study, With a Double-blind Lead-in, to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) $106,577 24 payments
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab (REVAMP) $17,042 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.